Biography
Anderson received a B.S. degree in Biology (1988) and a B.S. degree in Pharmacy (1991) from the University of New Mexico. He earned his Doctor of Pharmacy degree (1995) from the University of Texas at Austin. Following his Pharm. D. degree he completed a 2-year pharmacotherapy residency at the University of Texas Health Sciences Center in San Antonio and the South Texas Veterans Medical Center in San Antonio.
Personal Statement
Anderson’s research interests are in cardiovascular pharmacotherapy, specifically as it relates to heart failure and primary and secondary ASCVD prevention, and health outcomes, particularly as they pertain to advanced pharmacist practice. Additionally, Dr. Anderson has ongoing research projects assessing the utilization of statins for primary prevention of ASCVD in the community pharmacy setting and evaluating the benefit of screening for silent atrial fibrillation in the community pharmacy and other healthcare settings.
Areas of Specialty
Heart failure
Cardiovascular risk reduction
Atrial fibrillation
Advanced pharmacist practice
Health outcomes
Education
PharmD, University of Texas at Austin, 1995
BS, University of New Mexico, 1991 (Pharmacy)
BS, University of New Mexico, 1988 (Biology)
Certifications
Board Certified Pharmacotherapy Specialist
Achievements & Awards
Pharmacist of the Year, New Mexico Society of Health-System Pharmacists, 2005
University of New Mexico College of Pharmacy Teacher of the Year, 2007
Innovative Pharmacy Practice Award. Presented by the New Mexico Pharmacists Association, 2008
Dorothy Dillon Memorial Award. Awarded for significant contributions to hospital pharmacy practices. Presented by the New Mexico Society of Health-System Pharmacists, 2010
Distinguished Alumni Award, University of New Mexico College of Pharmacy, 2018
Pharmacy Champion Award 2021 - American Society of Hospital Pharmacist Board of Directors. Co-recipient with Melanie Dodd, PharmD, Keenan Ryan, PharmD, and Dale Tinker.
Courses Taught
Developed, organized, coordinated, and taught PHRM 750 Physical Assessment and Clinical Skills course since 1999. Successful completion of this course is a requirement for certification as a pharmacist clinician.
Instructor of Record for PHRM 850 Integrated Pharmacotherapy VIII and provide instruction in the topics of therapeutic management of hyperlipidemia in PHRM 820 (Integrated Pharmacotherapy I) and the therapeutic management of heart failure in PHRM 830 (Integrated Pharmacotherapy III).
Developed, organized, and serve as Instructor of Record for PHRM 889 Advanced Pharmacy Practice Seminar. This course involves the provision of multiple professional development seminars provided to P4 students during their APPE year. As well the course involves coordination of NAPLEX preparatory examinations that cover topics that correlate with the P4 students APPE. The students complete 7 of these APPE-specific examinations along with a baseline NAPLEX readiness assessment and a NAPLEX prep examination during graduation week. The course also includes graduation week activities including a live MPJE prep review and prescriptive authority certification day.
Research and Scholarship
Pham NT, Yon CM, Anderson JR, Dodd MA, Roberts MH, Yang SM, Ray GM. Awareness and perceptions of advanced practice pharmacists among health care providers in New Mexico. J Am Pharm Assoc (2003). 2020 Oct 10: https://doi.org/10.1016/j.japh.2020.10.001.
Wheeler E, Walsh-Wilcox M, Shah M, Achrekar A, Anderson JR, Walker MK. Interactive effects of omega-3 polyunsaturated fatty acids and secondhand smoke in mice and human subjects. Cardiovasc Toxicol 2020: https://doi.org/10.1007/s12012-020-09601-6.
Anderson JR, Hunter T, Dinallo JM, Glaser D, Roybal LK, Segovia A, Raley R, Bleske BE. Population screening for atrial fibrillation by student pharmacists at health fairs. J Am Pharm Assoc 2020;60: e52-e57.
Shen X, Bachyrycz A, Anderson JR, Tinker D, Raisch DW. Improving the effectiveness of pharmacist-assisted tobacco cessation: a study of participant- and pharmacy-specific differences in quit rates. Ann Pharmacother 2015;49(3):303-310.
Khan N, Anderson JR, Du J, Tinker D, Bachyryz A, Namdar R. Smoking cessation and its predictors: results from community-based pharmacy tobacco cessation program in New Mexico. Ann Pharmacother 2012;46:1198-204.